LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 207 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $487,809 | -22.3% | 8,141 | -6.5% | 0.01% | -25.0% |
| Q2 2023 | $628,063 | -5.8% | 8,711 | -3.9% | 0.01% | -11.1% |
| Q1 2023 | $667,042 | -51.6% | 9,068 | -56.0% | 0.01% | 0.0% |
| Q4 2022 | $1,377,816 | +17.1% | 20,626 | +50.9% | 0.01% | -47.1% |
| Q3 2022 | $1,177,000 | -9.0% | 13,673 | -5.6% | 0.02% | 0.0% |
| Q2 2022 | $1,293,000 | -27.4% | 14,489 | -8.5% | 0.02% | -10.5% |
| Q1 2022 | $1,781,000 | -26.1% | 15,834 | +1.4% | 0.02% | -24.0% |
| Q4 2021 | $2,411,000 | – | 15,609 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |